Pirtobrutinib and Venetoclax in Waldenström Macroglobulinemia
Clinical trial NCT05734495 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05734495
- Sponsor
- Dana-Farber Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-02
- Primary completion
- 2029-01-25
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.